These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 3351378
1. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition. Yatziv S, Newburg DS, Livni N, Barfi G, Kolodny EH. J Lab Clin Med; 1988 Apr; 111(4):416-20. PubMed ID: 3351378 [Abstract] [Full Text] [Related]
3. Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase alpha. Kacher Y, Golan A, Pewzner-Jung Y, Futerman AH. Blood Cells Mol Dis; 2007 Jun; 39(1):124-9. PubMed ID: 17482853 [Abstract] [Full Text] [Related]
4. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase. Daniels LB, Glew RH, Radin NS, Vunnam RR. Clin Chim Acta; 1980 Sep 25; 106(2):155-63. PubMed ID: 6773704 [Abstract] [Full Text] [Related]
5. beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell. Newburg DS, Yatziv S, McCluer RH, Raghavan S. Biochim Biophys Acta; 1986 Jun 11; 877(1):121-6. PubMed ID: 3087427 [Abstract] [Full Text] [Related]
6. Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes. Trajkovic-Bodennec S, Bodennec J, Futerman AH. Blood Cells Mol Dis; 2004 Jun 11; 33(1):77-82. PubMed ID: 15223015 [Abstract] [Full Text] [Related]
7. Recombinant glucocerebrosidase uptake by Gaucher disease human osteoblast culture model. Lamghari M, Barrias CC, Sá Miranda C, Barbosa MA. Blood Cells Mol Dis; 2005 Jun 11; 35(3):348-54. PubMed ID: 16125984 [Abstract] [Full Text] [Related]
8. Effectors of three beta-glucosidases from human liver. Daniels LB, Gnarra JR, Glew RH. Prog Clin Biol Res; 1982 Jun 11; 95():333-55. PubMed ID: 6812077 [Abstract] [Full Text] [Related]
9. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors. Freas-Lutz DL, Correll PH, Dougherty SF, Xu L, Pluznik DH, Karlsson S. Exp Hematol; 1994 Aug 11; 22(9):857-65. PubMed ID: 8062885 [Abstract] [Full Text] [Related]
10. Chemical inhibition of β-glucocerebrosidase does not affect phagocytosis and early containment of Leishmania by murine macrophages. Ribeiro H, Rocha MI, Castro H, Macedo MF. Exp Parasitol; 2020 Sep 11; 216():107939. PubMed ID: 32535115 [Abstract] [Full Text] [Related]
11. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease. Daniels LB, Glew RH, Diven WF, Lee RE, Radin NS. Clin Chim Acta; 1981 Sep 11; 115(3):369-75. PubMed ID: 6794954 [Abstract] [Full Text] [Related]
12. Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies. Beutler E, Dale GL. Prog Clin Biol Res; 1982 Sep 11; 95():703-16. PubMed ID: 7122644 [Abstract] [Full Text] [Related]
15. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine. Grabowski GA, Dinur T, Osiecki KM, Kruse JR, Legler G, Gatt S. Am J Hum Genet; 1985 May 11; 37(3):499-510. PubMed ID: 4003396 [Abstract] [Full Text] [Related]